CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Randomized, Placebo-controlled, Double-blind, 16 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02153645
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:47.842449+00:00
Published At: 2019-04-02T00:00:00+00:00
Record Updated At: 2022-02-16
Results Posted At: 2019-04-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Parkinson\u0027s Disease", "Levodopa Induced Dyskinesias (LID)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-02-16"
protocolSection.identificationModule.nctId: "NCT02153645"
protocolSection.identificationModule.officialTitle: "A Multicenter, Randomized, Placebo-controlled, Double-blind, 16 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson\u0027s Disease Subjects With Levodopa-Induced Dyskinesias"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-04-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.